M Therapeutics Inc., an early-stage biotechnology company developing treatments for neuropsychiatric and neurodegenerative diseases, today announced that the company will provide its novel compounds ...
BETHESDA, MD & GAITHERSBURG, MD, USA I October 16 2024 I Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools ...
Years of growing resistance to antibiotics have sparked an urgent global health crisis, giving rise to challenging biological threats and the emergence of more dangerous ...
The Michael J. Fox Foundation (MJFF) has launched a major initiative to rapidly expedite development of therapeutic strategies targeting LRRK2. Called the LRRK2 Investigative Therapeutics Exchange ...